phrykt

ProMIS Neurosciences Inc. (PMN): who owns it and who trades it

As of Nov 16, 2026, PMN insiders reported 11 purchases worth $8.9M in the last 12 months. The largest buyer was Fan Yu (10% owner), with $8.5M. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling ProMIS Neurosciences

From the latest filings

Overall: more buying than selling. Insiders and famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns PMN

27 funds and institutions reported PMN shares worth $84.3M at the end of Q2 2026, about 71% of the company. The largest holder is Jupiter Topco LLC with 14.4%.

Funds and institutions (13F) 71%Everyone else 29%

10 largest owners, by share of the company

Jupiter Topco LLC14.4%
Deep Track Capital, LP9.3%
Wellington Management Group LLP7.8%
Ally Bridge Group (NY) LLC6.9%
Trails Edge Capital Partners, LP6.2%
Woodline Partners LP4.9%
Yu Fan3.7%
Sphera Funds Management Ltd.3.6%
Squadron Capital Management LLC3.6%
Ikarian Capital, LLC2.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Jupiter Topco LLC1.29M14.42%$17MNew
Deep Track Capital, LP835,6559.32%$11MNo change
Wellington Management Group LLP696,3787.77%$9.2MNo change
Ally Bridge Group (NY) LLC620,3196.92%$8.2M+50%
Trails Edge Capital Partners, LP557,1036.21%$7.3MNo change
Woodline Partners LP441,9114.93%$5.8M+12%
Yu Fan329,7603.68%$4.3MNo change
Sphera Funds Management Ltd.325,5913.63%$4.3MNo change
Squadron Capital Management LLC324,9773.62%$4.3MNo change
Ikarian Capital, LLC205,0002.29%$2.7M+273%
Ameriprise Financial Inc185,7002.07%$2.4MNew
Adage Capital Partners Gp, L.l.c.164,2751.83%$2.2M+18%
683 Capital Management, LLC95,0001.06%$1.3M+2%
ADAR1 Capital Management, LLC92,8501.04%$1.2M-3%
Great Point Partners LLC86,1500.96%$1.1M-77%
Boothbay Fund Management, LLC62,0780.69%$817K+287%
Millennium Management LLC56,0450.62%$738K-28%
Bank of Montreal11,3710.13%$150KNew
Seven Fleet Capital Management LP10,6000.12%$139KNo change
Morgan Stanley7,5590.08%$99.5KNew

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, PMN insiders reported $8.9M of open-market purchases and $0 of sales.

Purchases, 12 months
$8.9M
11 trades, 5 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Nov 4, 2026
Filed Nov 6, 2026

Purchases and sales by month

$8.5M$8.5MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 4, 2026Eugene WilliamsDirectorPurchase26,500$3.43$90.9KForm 4
Nov 2, 2026Neil CashmanDirectorPurchase10,000$3.86$38.6KForm 4
Oct 30, 2026Eugene WilliamsDirectorPurchase1,316$3.99$5.3KForm 4
Aug 5, 2026Johanne KaplanChief Development OfficePurchase2,280$13.30$30.3KForm 4
Apr 22, 2026Patrick D. KirwinDirectorPurchase4,000$11.33$45.3KForm 4
Mar 5, 2026Eugene WilliamsDirectorPurchase2,000$24.40$48.8KForm 4
Mar 4, 2026Eugene WilliamsDirectorPurchase2,000$24.00$48KForm 4
Mar 3, 2026Eugene WilliamsDirectorPurchase1,000$21.89$21.9KForm 4
Mar 2, 2026Eugene WilliamsDirectorPurchase1,000$22.53$22.5KForm 4
Feb 19, 2026Johanne KaplanChief Development OfficePurchase1,629$15.35$25KForm 4
Feb 3, 2026Fan Yu +410% ownerPurchase700,741$12.13$8.5MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Fan Yu10% owner$8.5M–Feb 3, 2026
Eugene WilliamsDirector$237K–Nov 4, 2026
Johanne KaplanChief Development Officer$55.3K–Aug 5, 2026
Patrick D. KirwinDirector$45.3K–Apr 22, 2026
Neil CashmanChief Scientific Officer, Director$38.6K–Nov 2, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PMN short interest

Low short interest. 3.1% of PMN shares are sold short: about 1 share in 33. Over the last 12 reports the number of shares short went up 65%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 274,761 PMN shares were sold short, 3.1% of the shares outstanding, up 11.8% from the report before. At the average daily volume of 178,207 shares, buying them all back would take about 1.5 trading days (days to cover).

Shares short, % of all shares

3.06%May 15Oct 303.36%

Days to cover

1.5May 15Oct 3012.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026274,7613.06%+12%178,2071.5
Oct 15, 2026245,8382.74%+3%34,4307.1
Sep 30, 2026238,5842.66%-1%33,5267.1
Sep 15, 2026240,0002.68%-9%49,9444.8
Aug 31, 2026263,7442.94%-6%28,0299.4
Aug 14, 2026281,1343.13%-1%26,13510.8
Jul 31, 2026283,7263.16%+20%267,0821.1
Jul 15, 2026235,7792.63%+16%75,2193.1
Jun 30, 2026203,9262.27%+2%42,0904.8
Jun 15, 2026200,8652.24%+6%19,57010.3
May 29, 2026188,7902.11%+13%22,0748.6
May 15, 2026166,5881.86%+18%35,8694.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

ProMIS Neurosciences company events

ProMIS Neurosciences filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Aug 13, 2026.

  1. Aug 13, 2026ResultsReleased financial results. Filing
  2. Jul 28, 2026AnnouncementThe Company issued the Press Release. Filing
  3. May 20, 2026LeadershipAs further described in Item 5.07 below, the stockholders of ProMIS Neurosciences Inc. approved an amendment to the Company’s 2025 Stock Option and Incentive Plan at the Company’s 2026 Annual Meeting of Stockholders held on May 20, 2026. Filing
  4. May 12, 2026ResultsReleased financial results. Filing
  5. Mar 25, 2026ResultsReleased financial results. Filing
  6. Jan 30, 2026AgreementProMIS Neurosciences Inc. entered into a Securities Purchase Agreement with selected investors that qualify as “accredited investors”, as defined in Rule 501(a) of Regulation D promulgated under the United States Securities Act of 1933, as amended, for the purpose of raising approximately $75… Filing
  7. Dec 16, 2025AnnouncementProMIS Neurosciences Inc. received a written notification from the Nasdaq Stock Market Listing Qualifications Staff indicating that the Company has regained compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market pursuant to NASDAQ Listing Rule… Filing
  8. Nov 24, 2025AnnouncementThe Company issued a press release announcing the Reverse Stock Split and other related information. Filing
  9. Nov 19, 2025VoteReported shareholder vote results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

ProMIS Neurosciences financials

Famous investors that hold PMN

2 of the 50 well-known investors we track reported holding PMN in their latest 13F filing. The largest position is Israel Englander's, worth $1.3M.

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 2026121,123$1.3M0.0%+116%
Ken Griffin · Citadel AdvisorsQ3 202622,902$248K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named PMN in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Great Point Partners, LLC13G/A6.8%
Nov 16, 2026Great Point Partners, LLC13G/A6.8%
Nov 12, 2026Adage Capital Management, L.P.13G7.7%
Nov 12, 2026Adage Capital Management, L.P.13G7.7%

Questions about ProMIS Neurosciences Inc. (PMN) stock

Who owns the most PMN stock?

The largest reported owner of ProMIS Neurosciences Inc. (PMN) is Jupiter Topco LLC, with 14.4% of the company. In total, 27 funds and institutions reported holding PMN at the end of Q2 2026, together about 71% of the shares. See the largest owners.

Are PMN insiders buying or selling?

In the last 12 months, PMN insiders reported 11 open-market purchases worth $8.9M and no sales. The latest trade was on Nov 4, 2026. See every trade.

What is the short interest in PMN?

As of Oct 30, 2026, 274,761 PMN shares were sold short, 3.1% of the shares outstanding, up 11.8% from the report before. At the average daily volume of 178,207 shares, buying them all back would take about 1.5 trading days (days to cover). See the history.

Which famous investors hold PMN?

2 of the 50 well-known investors we track reported PMN in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $1.3M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.